Lupin Ltd. (LUPIN)
BSE
Closed
Oct 9, 2026
Day's Range
1,942.0052 wk Range
1,900.30Overview - LUPIN - Lupin Ltd.
Key Statistics
Valuation
Enterprise Value
1.01T
P/E (Trailing)
‪20.76‬
P/E (Forward)
‪21.73‬
PEG Ratio
‪21.73‬
Price / Sales (TTM)
‪3.61‬
Price / Book
‪4.55‬
EV / EBITDA
‪16.67‬
Profitability
Gross Margin
‪74.57%‬
Profit Margin
‪17.47%‬
Operating Margin
‪25.83%‬
Return on Assets
‪10.75%‬
Return on Equity
‪24.52%‬
Ownership
Shares Outstanding
456.96M
Float
241.81M
Held by Insiders
‪47.04%‬
Held by Institutions
‪31.71%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪2,122.03‬
200-Day Avg
‪2,010.88‬
Dividends
Payout Ratio
‪12.71%‬
Frequency
Annual
Analyst Consensus
37 analysts
Average price target
‪₹ 2,306.18‬Market Cap - LUPIN - Lupin Ltd.
Peers - LUPIN - Lupin Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
- LUPINBSELupin Ltd.895.65BMarket Cap-0.53%52-week change20.77P/E (Trailing)‪17.47%‬Profit Margin
- DIVISLABBSEDivi's Laboratories Ltd.2.47TMarket Cap+29.72%52-week change84.62P/E (Trailing)‪26.04%‬Profit Margin
- LAURUSLABSBSELaurus Labs Ltd.1.07TMarket Cap+56.59%52-week change98.03P/E (Trailing)‪15.04%‬Profit Margin
- CIPLABSECipla Ltd.1.05TMarket Cap-20.00%52-week change23.19P/E (Trailing)‪16.25%‬Profit Margin
- DRREDDYBSEDr. Reddy's Laboratories Ltd.1.00TMarket Cap-2.69%52-week change17.73P/E (Trailing)‪16.36%‬Profit Margin
- AUROPHARMABSEAurobindo Pharma Ltd.980.78BMarket Cap+32.58%52-week change27.88P/E (Trailing)‪10.52%‬Profit Margin
- MANKINDBSEMankind Pharma Ltd.978.50BMarket Cap-3.07%52-week change47.92P/E (Trailing)‪13.85%‬Profit Margin
Profile Summary - LUPIN - Lupin Ltd.
About
Lupin Ltd. is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of branded and generic formulations, as well as active pharmaceutical ingredients (APIs). The company focuses on the cardiovascular, anti-asthma, anti-diabetic, CNS, and anti-infective…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
